Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama

Performance of a Point of Care Test for Detecting IgM and IgG Antibodies Against SARS-CoV-2 and Seroprevalence in Blood Donors and Health Care Workers in Panama

Novel severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the etiologic agent of the ongoing coronavirus disease 2019 (COVID-19) pandemic, which has reached 28 million cases worldwide in 1 year. The serological detection of antibodies against the virus will play a pivotal role in complem...

Full description

Bibliographic Details
Main Authors: Alcibiades Villarreal, Giselle Rangel, Xu Zhang, Digna Wong, Gabrielle Britton, Patricia L. Fernandez, Ambar Pérez, Diana Oviedo, Carlos Restrepo, María B. Carreirra, Dilcia Sambrano, Gilberto A. Eskildsen, Carolina De La Guardia, Julio Flores-Cuadra, Jean-Paul Carrera, Yamitzel Zaldivar, Danilo Franco, Sandra López-Vergès, Dexi Zhang, Fangjing Fan, Baojun Wang, Xavier Sáez-Llorens, Rodrigo DeAntonio, Ivonne Torres-Atencio, Isabel Blanco, Fernando Diaz Subía, Laiss Mudarra, Aron Benzadon, Walter Valverde, Lineth López, Nicolás Hurtado, Neyla Rivas, Julio Jurado, Aixa Carvallo, Juan Rodriguez, Yaseikiry Perez, Johanna Morris, Odemaris Luque, David Cortez, Eduardo Ortega-Barria, Rao Kosagisharaf, Ricardo Lleonart, Chong Li, Amador Goodridge
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-03-01
Series:Frontiers in Medicine
Subjects:
COVID-19
Panama
serology
biomarker
immunochromatographic assay
diagnosis
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full

Internet

https://www.frontiersin.org/articles/10.3389/fmed.2021.616106/full

Similar Items